Tenax Therapeutics, Inc. balance sheet
At the end of fiscal 2025, Tenax Therapeutics, Inc. had total assets of $104m, total liabilities of $7.2m and shareholders' equity of $97.1m. It held $97.6m in cash against $0 of debt.
Balance sheet
| Fiscal year | 2011Apr 2011 | 2012Apr 2012 | 2013Apr 2013 | 2014Apr 2014 | 2015Apr 2015 | 2016Dec 2016 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | — | — | — | 10 | 95 | 98 | 118 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Inventory | 0 | 0 | 0 | 0 | — | — | — | — | — |
| Total current assets | 2 | 3 | 2 | 59 | 18 | 14 | 97 | 104 | 122 |
| Goodwill | — | — | 0 | 11 | 11 | 0 | — | — | — |
| Total assets | 3 | 4 | 3 | 93 | 83 | 23 | 97 | 104 | 122 |
| Accounts payable | 1 | 1 | 1 | 0 | 1 | 1 | 3 | 6 | 7 |
| Total current liabilities | 2 | 3 | 2 | 3 | 5 | 6 | 5 | 7 | 8 |
| Long-term debt | 4 | 1 | 3 | 0 | — | — | — | — | — |
| Total debt | 5 | 1 | 5 | 0 | — | 0 | 0 | 0 | 0 |
| Total liabilities | 7 | 4 | 5 | 11 | 12 | 6 | 5 | 7 | 8 |
| Shareholders' equity | −4 | −0 | −2 | 83 | 70 | 17 | 92 | 97 | 114 |
| Shares outstanding | 117m | — | — | — | — | — | — | 37m | — |
| Quarter | 2014 Q3Oct 2014 | 2015 Q1Jan 2015 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 0 | — | — | — | — | — | — | — |
| Total current assets | 23 | — | 112 | 106 | 103 | 104 | 123 | 122 |
| Goodwill | 11 | — | — | — | — | — | — | — |
| Total assets | 89 | — | 112 | 106 | 103 | 104 | 123 | 122 |
| Accounts payable | 2 | — | 2 | 1 | 6 | 6 | 6 | 7 |
| Total current liabilities | 4 | — | 3 | 3 | 7 | 7 | 8 | 8 |
| Total liabilities | 12 | — | 3 | 3 | 7 | 7 | 8 | 8 |
| Shareholders' equity | 78 | — | 109 | 103 | 96 | 97 | 115 | 114 |
| Shares outstanding | 28m | — | 4m | 4m | 6m | 9m | 24m | 32m |